Award recordCONTRACT

HUNTSMAN CANCER HOSPITAL

PIID VA25912P0057· VHA· 259-NETWORK CONTRACT OFFICE 19· 6505 · DRUGS AND BIOLOGICALS· FY2012· $126,368 net obligations· UEI DLSRY17K7GY5· UT

Description

RADIOPHARMACEUTICAL DOSE FOR PET/CT STUDIES.

First action · last action
2011-11-17 · 2013-02-12
Transactions
3
First transaction's obligation
$323,700
Base + all options value (sum of deltas)
$126,368
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
446110 · PHARMACIES AND DRUG STORES

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$323,700$0Base award · 2011-11-17 · this action $323,700 · running total $323,700Modification P00001 · 2012-09-30 · this action -$166,000 · running total $157,700Modification P00002 · 2013-02-12 · this action -$31,333 · running total $126,368
  • Base2011-11-17+$323,700= $323,700
  • Mod P000012012-09-30-$166,000= $157,700
  • Mod P000022013-02-12-$31,333= $126,368
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2011-11-17+$323,700$323,700RADIOPHARMACEUTICAL DOSE FOR PET/CT STUDIES.
Mod P00001· FUNDING ONLY ACTION2012-09-30−$166,000$157,700RADIOPHARMACEUTICAL DOSE FOR PET/CT STUDIES.
Mod P00002· FUNDING ONLY ACTION2013-02-12−$31,333$126,368RADIOPHARMACEUTICAL DOSE FOR PET/CT STUDIES.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DLSRY17K7GY5)

AwardOffice · PSC / listingNet obligationsFY
36C25922N0061NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$67,760FY2022
36C25921N0044NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$92,015FY2021
36C25920N0036NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$119,735FY2020
36C25919N0011NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$156,695FY2019
36C25918N0159NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$148,405FY2018
VA25917D0358NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$0FY2017

Other recipients under 6505 from 259-NETWORK CONTRACT OFFICE 19 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25916E2832GRIFOLS USA LLC259-NETWORK CONTRACT OFFICE 19$16,949FY2016
VA25916E2677GRIFOLS THERAPEUTICS LLC259-NETWORK CONTRACT OFFICE 19$12,066FY2016
VA25916P2108BAXALTA US INC.259-NETWORK CONTRACT OFFICE 19$6,212FY2016
VA25916P1705MCKESSON CORPORATION259-NETWORK CONTRACT OFFICE 19$11,043FY2016
VA25916E2674CAREMARK RX, L.L.C.259-NETWORK CONTRACT OFFICE 19$17,262FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25912P0057_3600_-NONE-_-NONE- · retrieved 2026-09-26.